If you have been told you may need mohs surgery, it is natural to ask which skin cancers it is actually used for and why. This matters because mohs surgery is highly effective in the right situations, but it is not the best or most necessary option for every diagnosis.

Basal cell carcinoma is the most common reason for Mohs surgery

The skin cancer most commonly treated with mohs surgery is basal cell carcinoma, often called BCC. The British Association of Dermatologists says mohs surgery is most often used to treat basal cell carcinomas, particularly when they are in areas where preserving healthy skin matters, such as the head and neck.

This is one reason surgery is so often discussed for skin cancers on the nose, eyelids, lips, ears, temple, and cheeks. These are places where a standard wider excision can remove more healthy tissue than needed, while Mohs checks the margins in stages and removes more only where cancer remains. That tissue-sparing precision can make a real difference to both wound size and the final cosmetic result.

Squamous cell carcinoma can also be treated with Mohs surgery

Squamous cell carcinoma, or SCC, is another important skin cancer that may be treated with mohs surgery in selected cases. BAD guidance on SCC says that Mohs may be recommended in some circumstances, and its dedicated Mohs patient leaflet also lists SCC as one of the cancers that can be treated with this technique.

In practice, mohs surgery is often considered for SCC when the cancer has come back, has unclear borders, is in a high-risk facial area, or when preserving healthy tissue is especially important. Cancer Research UK says Mohs is particularly useful for skin cancers that have recurred, have not been completely removed before, are growing into surrounding tissue, or sit in delicate areas such as the eyes, ears, nose, and lips.

That means surgery is not only about the cancer type. It is also about the behaviour and location of the tumour. A straightforward SCC in a less visible area may still be managed well with standard excision, while a more complex SCC on the face may benefit much more from the staged Mohs approach. This is why specialist assessment matters before deciding on the best treatment route.

Some rare skin cancers may be suitable too

Although BCC and SCC are the main reasons patients are referred for mohs surgery, they are not the only possibilities. The BAD Mohs leaflet says the technique may also be used for several other rare skin cancers. Dr Arif Aslam’s site makes a similar point, explaining that mohs surgery is most effective for basal cell carcinoma and squamous cell carcinoma, while in some cases it may also be used for melanoma and other rare skin cancers.

This does not mean every rare tumour automatically needs surgery. It means the procedure can be considered when the cancer is difficult to define, has come back, is in a cosmetically sensitive site, or when preserving healthy tissue is likely to improve the final outcome. The decision is usually based on a combination of diagnosis, pathology, body site, and how much benefit Mohs is likely to offer over simpler surgical approaches.

What about melanoma?

Melanoma needs more careful wording. For most melanoma, the usual treatment remains standard excision and wide local excision rather than routine mohs surgery. That is why Mohs is not generally described as the default treatment for melanoma in the way it is for BCC.

However, there are selected situations where surgery may be considered. DermNet says a special tissue-sparing technique such as Mohs or staged mapped excisions may be used for a large melanoma in situ, and it also notes that tissue-sparing Mohs may be worthwhile for lentigo maligna melanoma when the margins are frequently unclear. Dr Arif Aslam’s melanoma page similarly says Mohs can be an ideal choice for eligible early-stage melanomas in cosmetically sensitive locations, while not being suitable for all melanoma cases.

That is why the simplest answer is this: mohs surgery most commonly treats basal cell carcinoma, can be used for selected squamous cell carcinomas, may be used for some rarer skin cancers, and is only used for melanoma in carefully chosen cases rather than as a routine option. The exact choice depends on the cancer type, where it is on the body, whether it has recurred, and how important it is to preserve surrounding healthy tissue.

If you are trying to work out whether mohs surgery is right for your skin cancer, the best next step is a specialist review based on your diagnosis, the site of the lesion, and the treatment outcome you want to protect. That kind of tailored advice will tell you far more than the procedure name on its own.